Zurcher Kantonalbank (Zurich Cantonalbank) - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 115 filers reported holding AKERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$499,629
+37.4%
9,878
+26.8%
0.00%0.0%
Q2 2023$363,622
+62.0%
7,788
+32.7%
0.00%
+100.0%
Q1 2023$224,510
-37.3%
5,868
-10.2%
0.00%
-50.0%
Q4 2022$358,173
+186.5%
6,536
+77.4%
0.00%
+100.0%
Q3 2022$125,000
+257.1%
3,6840.0%0.00%
Q2 2022$35,000
-35.2%
3,684
-3.9%
0.00%
Q1 2022$54,000
+8.0%
3,835
+62.6%
0.00%
Q4 2021$50,000
-5.7%
2,3590.0%0.00%
Q3 2021$53,000
-10.2%
2,3590.0%0.00%
Q2 2021$59,000
-13.2%
2,3590.0%0.00%
Q1 2021$68,000
+11.5%
2,3590.0%0.00%
Q4 2020$61,000
-16.4%
2,3590.0%0.00%
-100.0%
Q3 2020$73,0002,3590.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$179,29657.03%
Redmile Group, LLC 2,632,912$144,283,5785.90%
Avidity Partners Management LP 3,825,000$209,610,0004.54%
COMMODORE CAPITAL LP 537,076$29,4324.44%
Atlas Venture Life Science Advisors, LLC 594,251$32,564,9553.92%
Paradigm Biocapital Advisors LP 604,544$33,129,0113.89%
Yiheng Capital Management, L.P. 1,468,905$80,495,9943.56%
Altium Capital Management LP 125,000$6,850,0003.48%
Tri Locum Partners LP 128,851$7,061,0002.86%
SILVERARC CAPITAL MANAGEMENT, LLC 172,100$9,431,0802.70%
View complete list of AKERO THERAPEUTICS INC shareholders